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The aims of the thesis: Data processing of patients, who underwent allogenic 
hematopoietic stem cell transplantation in a period from 2010 to 2014 in University 
Hospital Hradec Kralove and whose state of chimerism was monitored at the Section of 
Molecular Biology at the Institute of Clinical Biochemistry and Diagnostics. 
Consequently, analysis of the possible relationship between selected clinical parameters 
and used genetic markers for chimerism quantification was carried out after the 
processing of acquired data. Finally, the possible influence of treatment success and 
mortality by chosen clinical parameters was evaluated. 
Methods: Analysis of short tandem repeat loci, which uses genetic variability between 
donor and recipient of transplanted graft, was employed for quantification of post-
transplant chimerism. DNA of donor and recipient was isolated by QIAmp DNA Blood 
Mini Kit (QIAGEN, Germany), amplified by AmpFlSTR Identifier Kit (Applied 
Biosystems, USA) and separated by capillary electrophoresis (analyzer ABI 3130-4, 
Applied Biosystems, USA). 
Conclusion: Markers D21S11, D2S1338, THO1, FGA a D3S1358 were among the most 
informative ones. Proceeded parallelly, they were sufficient for finding at least one 
informative and useful marker for chimerism quantification in the patients from the 
analyzed group. Transplantation couples with the 10/10 antigens in HLA system had 
statistically less useful markers, as well as the relational couples. Higher age and 
diagnosis of chronic lymphatic leukemia were proven as a negative prognostic factor for 
treatment success and post-transplant mortality. 
